Background: A 16-year-old girl presented with multiple dusky red to brown-colored papules with centrally adherent scales scattered over the trunk and extremities (with sparing of the face), interspersed with multiple faint hypopigmented macules [ Figure 1 ]. The lesions had started appearing three years back with gradual progression. The self-healing lesions had left the hypopigmented macules with no varioliform scars. Occasional itching was the only symptom. There was no history of eruption of crops of vesicular/hemorrhagic/crusted papules, fever, painful lymphadenopathy, or systemic symptoms.
Polarized
dermoscopic examination (Escope videodermoscope, ×20) from the truncal lesions revealed yellowish-orange to light brown-colored structureless areas, with focal superficial scales, and multiple scattered dark brown-black colored granules, globules, and clods. Only a few scattered dotted and nondotted vessels could be appreciated. Focal areas of hypopigmentation were seen in the lesional periphery [ Figure 2 ].
A clinicodermoscopic diagnosis of pityriasis
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For reprints contact: reprints@medknow.com lichenoides chronica (PLC) was confirmed on histopathology that revealed small mounds of parakeratosis and epidermal infiltration by lymphocytes and red blood cells (RBCs). The dermoepidermal junction showed occasional necrotic keratinocytes. Focal interface vacuolar change and sparse superficial perivascular lymphocytic infiltrate with extravasation of RBCs were seen in the papillary dermis [ Figure 3 ]. Focal melanophages were also seen in the papillary and mid-dermis.
Pityriasis lichenoides (PL) constitutes a spectrum of skin disorders with acute (pityriasis lichenoides et varioliformis acuta [PLEVA]) and chronic (PLC) forms.
Approximately 20% of cases occur in children. [1] The etiology of PL remains uncertain. Although inflammatory response triggered by an infection has been proposed by many, the possibility of PL representing a T-cell lymphoproliferative disorder has not been ruled out. PLEVA and PLC represent a continuous spectrum with overlap in presentation. [2] In contrast to the abrupt crops of vesicular to necrotic erythematous macules and papules accompanied with systemic symptoms are archetypical of PLEVA, lesions of PLC are milder, have a gradual onset, and heal with postinflammatory hypo-(PIHy) or hyperpigmentation (PIH). The varioliform scarring of PLEVA is, however, not seen in PLC. Dermoscopy of PLC has been detailed by Errichetti et al. in seven Caucasian patients, the most common finding being orange-yellowish structureless areas, followed by focally distributed nondotted and dotted vessels, and scattered hypopigmented areas. [3] In contrast with the dermoscopic findings of PLC seen in white skin, we observed an add-on brownish hue over the yellowish-orange areas, only a few vessels but multiple scattered dark-brown-black granules, globules, and clods. Although conjectural, we believe that these additional pigmented structures suggest post inflammatory hyperpigmention, a specific dermoscopic finding described commonly in inflammatory dermatoses in the darker skin types. [4] The difficulty in observing vascular structures may also be attributable to the predominant pigmented background. Errichetti et al. have histologically correlated the orange-yellowish structureless areas of PLC to the presence of hemosiderin degradation products stemming from extravasated RBCs, and the vascular components to dilatation of superficial dermal vessels. [3] The dermoscopic differentiation of PLC from some of its close differentials is given in Table 1 .
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